CSPC Innovation Pharmaceutical Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300765
  • 1d0.11%
  • 1w1.86%
  • 1m-10.00%
  • 1y205.17%
ATH
  • ATH Price$47.65
  • ATH Date2023-12-06
  • % since ATH-21.80%
  • % to ATH27.89%
ATL
  • ATL Price$6.32
  • ATL Date2020-02-03
  • % from ATL489.44%
  • Last Low Price$24.8
  • Last Low Date2024-02-05
  • % From Last Low50.24%
IPO
  • IPO Price$29.36
  • % Current ROI USD126.91%
  • ATH Price$47.65
  • % ROI ATH 75,380.06%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300765"]

Key Data [addtoany]

Current price $37.26
Sector Consumer Defensive
Industry Packaged Foods
Today's High/Low $38.18/$36.65
Volume 7,758,877.00
Previous Close $37.22
52 Week High/Low $48.74/$10.91
Market Cap 43,574,943,744.00
P/E Ratio 56.3939
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0.93
Annualized Dividend $0.004
$37.26
[addtoany]

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity